Department of Pediatric Surgery, UCSF, San Francisco, Calif. 94143-0570 USA.
Fetal Diagn Ther. 2010;27(3):138-41. doi: 10.1159/000295176. Epub 2010 Mar 9.
To examine the outcomes of patients with twin reversed arterial perfusion (TRAP) sequence in which the acardiac twin was <or=50% the weight of the pump twin.
This was a retrospective study conducted with institutional review board approval. The records of all patients referred to UCSF for suspected diagnosis of TRAP between 1994 and 2009 were reviewed (n = 76). Patients with pregnancies complicated by TRAP with an acardiac twin <or=50% the weight of the pump twin were included (21 patients). Exclusion criteria were loss to follow-up (1 patient) and syndromic abnormalities in the pump twin (2 patients).
Of the 18 patients with viable pregnancies that met the criteria for analysis, 7 (39%) underwent radiofrequency ablation (RFA) of the acardiac twin and 11 (61%) underwent conservative management. None of the pump twins in either group had hydrops fetalis. Three of the 11 acardiac twins in the conservative management group did not undergo RFA because they did not have blood flow at presentation to UCSF. Survival to delivery was 100% (7/7) in the RFA group and 91% (10/11) in the conservative management group. When we eliminated from our analysis the 3 pregnancies in the conservative management group without blood flow to the acardiac twin, survival to delivery was 88% (7/8). The single death occurred in 1 of the 3 monochorionic-monoamniotic pregnancies in the conservative management group, all of whom had blood flow to the acardiac twin. There were no statistically significant differences in gestational age at delivery, birth weight or survival between the RFA and conservative management groups, even after stratification by blood flow.
Conservative management with close monitoring appears to be a safe option for TRAP pregnancies in which the acardiac twin is <or=50% the weight of the pump twin.
探讨重量≤泵胎 50%的无心畸形儿在双胎反向动脉灌注(TRAP)序列中的患者结局。
本研究为回顾性研究,经机构审查委员会批准。1994 年至 2009 年间,所有疑似 TRAP 而转诊至旧金山加利福尼亚大学的患者记录均被审查(n=76)。将 TRAP 合并无心畸形儿且无心畸形儿重量≤泵胎 50%的患者纳入研究(21 例)。排除标准为随访丢失(1 例)和泵胎综合征异常(2 例)。
符合分析标准的 18 例有活力妊娠患者中,7 例(39%)接受了无心畸形儿射频消融术(RFA),11 例(61%)接受了保守治疗。两组泵胎均无胎儿水肿。在保守治疗组的 11 例无心畸形儿中,有 3 例因就诊时无心畸形儿无血流而未行 RFA。RFA 组的存活率为 100%(7/7),保守治疗组为 91%(10/11)。在保守治疗组中,当我们排除了 3 例无心畸形儿无血流的妊娠时,存活率为 88%(7/8)。在保守治疗组的 3 例单绒毛膜-单羊膜妊娠中,1 例死亡,所有患者的无心畸形儿均有血流。即使在按血流分层后,RFA 组和保守治疗组的分娩时的孕龄、出生体重或存活率均无统计学差异。
对于无心畸形儿重量≤泵胎 50%的 TRAP 妊娠,密切监测下的保守治疗似乎是一种安全的选择。